{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:36:53Z","timestamp":1795030613816,"version":"4.10.2"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Randomized trials in pregnancy are extremely challenging, and observational studies are often the only option to evaluate medication safety during pregnancy. However, such studies are often susceptible to immortal time bias if treatment initiation occurs after time zero of follow-up. We describe how emulating a sequence of target trials avoids immortal time bias and apply the approach to estimate the safety of antibiotic initiation between 24 and 37 weeks gestation on preterm delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The Tsepamo Study captured birth outcomes at hospitals throughout Botswana from 2014 to 2021. We emulated 13 sequential target trials of antibiotic initiation versus no initiation among individuals presenting to care &lt;24 weeks, one for each week from 24 to 37 weeks. For each trial, eligible individuals had not previously initiated antibiotics. We also conducted an analysis susceptible to immortal time bias by defining time zero as 24 weeks and exposure as antibiotic initiation between 24 and 37 weeks. We calculated adjusted risk ratios (RR) and 95% confidence intervals (CI) for preterm delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of 111,403 eligible individuals, 17,009 (15.3%) initiated antibiotics between 24 and 37 weeks. In the sequence of target trials, RRs (95% CIs) ranged from 1.04 (0.90, 1.19) to 1.24 (1.11, 1.39) (pooled RR: 1.11 [1.06, 1.15]). In the analysis susceptible to immortal time bias, the RR was 0.90 (0.86, 0.94).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Defining exposure as antibiotic initiation at any time during follow-up after time zero resulted in substantial immortal time bias, making antibiotics appear protective against preterm delivery. Conducting a sequence of target trials can avoid immortal time bias in pregnancy studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ede.0000000000001601","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T12:02:34Z","timestamp":1676894554000},"page":"430-438","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":50,"title":["Emulating Target Trials to Avoid Immortal Time Bias \u2013 An Application to Antibiotic Initiation and Preterm Delivery"],"prefix":"10.1097","volume":"34","author":[{"given":"Ellen C.","family":"Caniglia","sequence":"first","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine"},{"name":"Botswana-Harvard AIDS Institute Partnership"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Zash","sequence":"additional","affiliation":[{"name":"Botswana-Harvard AIDS Institute Partnership"},{"name":"Beth Israel Deaconess Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Fennell","sequence":"additional","affiliation":[{"name":"Harvard T.H. Chan School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modiegi","family":"Diseko","sequence":"additional","affiliation":[{"name":"Botswana-Harvard AIDS Institute Partnership"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Mayondi","sequence":"additional","affiliation":[{"name":"Botswana-Harvard AIDS Institute Partnership"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Heintz","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mompati","family":"Mmalane","sequence":"additional","affiliation":[{"name":"Botswana-Harvard AIDS Institute Partnership"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Makhema","sequence":"additional","affiliation":[{"name":"Botswana-Harvard AIDS Institute Partnership"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Lockman","sequence":"additional","affiliation":[{"name":"Botswana-Harvard AIDS Institute Partnership"},{"name":"Harvard T.H. Chan School of Public Health"},{"name":"Brigham and Women\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunni L.","family":"Mumford","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor J.","family":"Murray","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Hern\u00e1ndez-D\u00edaz","sequence":"additional","affiliation":[{"name":"Harvard T.H. Chan School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Botswana-Harvard AIDS Institute Partnership"},{"name":"Harvard T.H. Chan School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"R1-20250801","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.","volume":"79","author":"Hern\u00e1n","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"R2-20250801","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology.","volume":"167","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"key":"R3-20250801","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/pds.5504","article-title":"Time-related biases in perinatal pharmacoepidemiology: a systematic review of observational studies.","volume":"31","author":"Ukah","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R4-20250801","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/bdra.23271","article-title":"Immortal time bias in observational studies of drug effects in pregnancy.","volume":"100","author":"Matok","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R5-20250801","doi-asserted-by":"crossref","first-page":"307.e1","DOI":"10.1016\/j.ajog.2014.09.028","article-title":"Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure.","volume":"212","author":"Daniel","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20250801","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/EDE.0b013e3182a6d9aa","article-title":"Immortal time bias in the study of stillbirth risk factors: the example of gestational diabetes.","volume":"24","author":"Hutcheon","year":"2013","journal-title":"Epidemiology"},{"key":"R7-20250801","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/09622802211065158","article-title":"A potential outcomes approach to defining and estimating gestational age-specific exposure effects during pregnancy.","volume":"31","author":"Schnitzer","year":"2022","journal-title":"Stat Methods Med Res"},{"key":"R8-20250801","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/aje\/kww043","article-title":"Risk of preterm or small-for-gestational-age birth after influenza vaccination during pregnancy: caveats when conducting retrospective observational studies.","volume":"184","author":"Vazquez-Benitez","year":"2016","journal-title":"Am J Epidemiol"},{"key":"R9-20250801","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyaa252","article-title":"Educational note: addressing special cases of bias that frequently occur in perinatal epidemiology.","volume":"50","author":"Neophytou","year":"2021","journal-title":"Int J Epidemiol"},{"key":"R10-20250801","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.3390\/ijerph17186465","article-title":"Warning of immortal time bias when studying drug safety in pregnancy: application to late use of antibiotics and preterm delivery.","volume":"17","author":"Corrao","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"R11-20250801","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40471-019-0180-5","article-title":"Immortal time bias in epidemiology.","volume":"2019","author":"Platt","year":"2019","journal-title":"Curr Epidemiol Rep"},{"key":"R13-20250801","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available.","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"R14-20250801","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/0962280211403603","article-title":"Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease.","volume":"22","author":"Danaei","year":"2013","journal-title":"Stat Methods Med Res"},{"key":"R15-20250801","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jclinepi.2017.11.021","article-title":"Electronic medical records can be used to emulate target trials of sustained treatment strategies.","volume":"96","author":"Danaei","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"R16-20250801","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/M16-0758","article-title":"Effectiveness of screening colonoscopy to prevent colorectal cancer among medicare beneficiaries aged 70 to 79 years: a prospective observational study.","volume":"166","author":"Garc\u00eda-Alb\u00e9niz","year":"2017","journal-title":"Ann Intern Med"},{"key":"R17-20250801","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10654-017-0287-2","article-title":"The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening.","volume":"32","author":"Garc\u00eda-Alb\u00e9niz","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R18-20250801","doi-asserted-by":"crossref","first-page":"e1322","DOI":"10.1212\/WNL.0000000000010433","article-title":"Emulating a target trial of statin use and risk of dementia using cohort data.","volume":"95","author":"Caniglia","year":"2020","journal-title":"Neurology"},{"key":"R19-20250801","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/s41591-019-0597-x","article-title":"Avoidable flaws in observational analyses: an application to statins and cancer.","volume":"25","author":"Dickerman","year":"2019","journal-title":"Nat Med"},{"key":"R20-20250801","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10654-017-0293-4","article-title":"Target trial emulation: teaching epidemiology and beyond.","volume":"32","author":"Labrecque","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R21-20250801","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.fertnstert.2022.02.003","article-title":"Effectiveness and safety of intrauterine insemination vs. assisted reproductive technology: emulating a target trial using an observational database of administrative claims.","volume":"117","author":"Chiu","year":"2022","journal-title":"Fertil Steril"},{"key":"R22-20250801","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/QAD.0000000000001673","article-title":"Emulating a target trial of antiretroviral therapy regimens started before conception and risk of adverse birth outcomes.","volume":"32","author":"Caniglia","year":"2018","journal-title":"AIDS"},{"key":"R24-20250801","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1186\/s12884-022-05101-3","article-title":"Timing and severity of COVID-19 during pregnancy and risk of preterm birth in the International Registry of Coronavirus Exposure in Pregnancy.","volume":"22","author":"Smith","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"R25-20250801","doi-asserted-by":"crossref","first-page":"e172222e172222","DOI":"10.1001\/jamapediatrics.2017.2222","article-title":"Comparative safety of antiretroviral treatment regimens in pregnancy.","volume":"171","author":"Zash","year":"2017","journal-title":"JAMA pediatr"},{"key":"R26-20250801","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJMoa1905230","article-title":"Neural-tube defects and antiretroviral treatment regimens in Botswana.","volume":"381","author":"Zash","year":"2019","journal-title":"N Engl J Med"},{"key":"R28-20250801","doi-asserted-by":"crossref","first-page":"ofab366","DOI":"10.1093\/ofid\/ofab366","article-title":"The Impact of Syndromic Management of Vaginal Discharge Syndrome on Adverse Birth Outcomes in Botswana.","volume":"8","author":"Fennell","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"R30-20250801","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/jci-2012-0002","article-title":"Causal inference under multiple versions of treatment.","volume":"1","author":"VanderWeele","year":"2013","journal-title":"J Causal Inference"},{"key":"R31-20250801","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/EDE.0000000000001222","article-title":"The Effect of Prenatal Treatments on Offspring Events in the Presence of Competing Events: An Application to a Randomized Trial of Fertility Therapies.","volume":"31","author":"Chiu","year":"2020","journal-title":"Epidemiology"},{"key":"R32-20250801","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/sim.8471","article-title":"A causal framework for classical statistical estimands in failure-time settings with competing events.","volume":"39","author":"Young","year":"2020","journal-title":"Stat Med"},{"key":"R33-20250801","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s10985-021-09530-8","article-title":"A generalized theory of separable effects in competing event settings.","volume":"27","author":"Stensrud","year":"2021","journal-title":"Lifetime Data Anal"},{"key":"R34-20250801","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2006-956773","article-title":"The role of inflammation and infection in preterm birth.","volume":"25","author":"Romero","year":"2007","journal-title":"Semin Reprod Med"},{"key":"R35-20250801","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-3016.2001.00007.x","article-title":"The role of infection in preterm labour and delivery.","volume":"15","author":"Romero","year":"2001","journal-title":"Paediatr Perinat Epidemiol"},{"key":"R39-20250801","doi-asserted-by":"crossref","first-page":"e56238","DOI":"10.1371\/journal.pone.0056238","article-title":"Trends in the distribution of gestational age and contribution of planned births in New South Wales, Australia.","volume":"8","author":"Nassar","year":"2013","journal-title":"PLoS One"},{"key":"R40-20250801","doi-asserted-by":"crossref","first-page":"Article 18","DOI":"10.2202\/1557-4679.1212","article-title":"When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data.","volume":"6","author":"Cain","year":"2010","journal-title":"Int J Biostat"},{"key":"R41-20250801","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41591-021-01490-8","article-title":"Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy.","volume":"27","author":"Dagan","year":"2021","journal-title":"Nat Med"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:08:45Z","timestamp":1754060925000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001601","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,20]]}}}